Compare AMRN & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRN | KRMD |
|---|---|---|
| Founded | 1989 | 1980 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 186.3M |
| IPO Year | 1993 | N/A |
| Metric | AMRN | KRMD |
|---|---|---|
| Price | $14.25 | $5.80 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $5.13 |
| AVG Volume (30 Days) | 80.1K | ★ 185.4K |
| Earning Date | 10-29-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $226,733,000.00 | $39,070,637.00 |
| Revenue This Year | N/A | $23.36 |
| Revenue Next Year | N/A | $18.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.12 |
| 52 Week Low | $7.08 | $1.86 |
| 52 Week High | $20.90 | $6.11 |
| Indicator | AMRN | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 37.60 | 57.77 |
| Support Level | $13.64 | $5.44 |
| Resistance Level | $14.49 | $5.88 |
| Average True Range (ATR) | 0.75 | 0.35 |
| MACD | -0.09 | -0.06 |
| Stochastic Oscillator | 23.77 | 50.00 |
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).